Stocks · US
PCVX
XNAS
Vaxcyte, Inc. Common Stock
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B3.98x
P/S—
EPS$-7.15
ROE-38.59%
ROA-33.91%
Dividend yield0.00%
Debt/Equity0.00
Free cash flow$-921M
Returns and 52-week range
1W+17.66%
1M+9.06%
3M+13.61%
6M+9.90%
1Y+56.35%
YTD+43.56%
52W high$90.75
52W low$39.87
From 52W high-26.50%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 이뮤니티바이오 | $11.0B | — | — | +19.93% |
| 쿠퍼 | $10.8B | 18.93 | 1.30 | -18.91% |
| BioMarin Pharmaceuticals Inc | $11.1B | 152.64 | 1.76 | -15.50% |
| Repligen Corp | $10.7B | 257.46 | 5.06 | +4.33% |
| Elanco Animal Health Incorporated Common Stock | $11.2B | — | 1.71 | -8.24% |
| Avantor, Inc. | $10.7B | — | 1.90 | +3.07% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.